Family Medicine · Chesapeake City, MD
NPI
1730282666
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2533 Augustine Herman Hwy, Suite A
Chesapeake City, MD, 21915
Phone (410) 885-5018
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
3,465 services
Medicare patients, 2024
302
Average age 72
Drug cost, 2024
$1.0M
11,022 prescriptions
Company payments, 2025
$1,021
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahnawaz A Khan was code 99214 (office e&m - established), 1,424 times for 289 patients. In total Shahnawaz A Khan billed 3,465 services in 52 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,424 | 289 | $85.79 | $122K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 992 | 260 | $12.40 | $12K |
| 36415 Venipuncture Blood Collection | Office | 227 | 118 | $8.65 | $1,964 |
| 99213 Office E&M - Established | Office | 170 | 117 | $61.62 | $10K |
| G0008 Administration of influenza virus vaccine | Office | 82 | 80 | $32.27 | $2,646 |
| 90656 Vaccine Product | Office | 70 | 70 | $0.01 | $0.7 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 13 | $0.78 | $43.56 |
| 96372 Injection Administration | Office | 52 | 12 | $10.24 | $533 |
| 99497 Care Management/Coordination | Office | 51 | 51 | $55.12 | $2,811 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 41 | 41 | $162.88 | $6,678 |
| 99406 Behavioral Health Services | Office | 29 | 12 | $14.46 | $419 |
| 81002 Clinical Chemistry | Office | 28 | 23 | $3.30 | $92.47 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 27 | 27 | $128.93 | $3,481 |
| 99204 Office E&M - New | Office | 21 | 21 | $91.60 | $1,924 |
| 93000 Electrocardiogram | Office | 21 | 20 | $10.27 | $216 |
By year: 2022 $159K for 2,491 services; 2023 $170K for 2,754 services; 2024 $173K for 3,465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 227 | 118 | $8.65 | $1,964 |
| 81002 Clinical Chemistry | 28 | 23 | $3.30 | $92.47 |
Medicare prescription drug claims, 2024
In 2024, the drug Shahnawaz A Khan prescribed most often to Medicare patients was Atorvastatin Calcium, with 488 prescriptions and refills. In total Shahnawaz A Khan wrote 11,022 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 488 | 1,116 | 125 | $5,012 |
| Levothyroxine Sodium Generic | 423 | 900 | 92 | $5,267 |
| Amlodipine Besylate Generic | 294 | 673 | 77 | $1,816 |
| Simvastatin Generic | 273 | 697 | 74 | $2,004 |
| Lisinopril Generic | 245 | 585 | 65 | $1,599 |
| Gabapentin Generic | 229 | 297 | 53 | $3,162 |
| Omeprazole Generic | 228 | 480 | 64 | $3,045 |
| Montelukast Sodium Generic | 218 | 453 | 59 | $2,374 |
| Sertraline Hcl Generic | 204 | 385 | 45 | $1,997 |
| Oxycodone Hcl Generic | 188 | 188 | 18 | $2,263 |
| Rosuvastatin Calcium Generic | 177 | 487 | 54 | $2,671 |
| Metformin Hcl Generic | 176 | 420 | 54 | $1,167 |
| Metoprolol Succinate Generic | 176 | 453 | 52 | $2,674 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 172 | 202 | 56 | $4,950 |
| Tamsulosin Hcl Generic | 159 | 368 | 44 | $3,209 |
Brand drugs: 1,345 claims; generic drugs: 9,629 claims; opioid claims: 554.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahnawaz A Khan $1,021 ($1,021 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $282.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $282 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $167 |
| Lilly USA, LLC LLY | 7 | $137 |
| Grifols USA, LLC | 4 | $92.03 |
| GlaxoSmithKline, LLC. GSK | 4 | $70.62 |
| Pfizer Inc. PFE | 3 | $62.34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $45.92 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32.47 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $25.31 |
| Tactile Systems Technology Inc TCMD | 1 | $25.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.